1,5 Tesla abdominal MRI
DeviceMeasurement of the fat and iron
NCT Number: NCT03200457
The study proposes to compare the results of two examinations at 1.5 and 3 Tesla obtained on the same day on a series of 80 patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hôpital St Vincent du Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France
Quantification of hepatic iron by MRI is validated at 1.5 Tesla on a small number of subjects with some discrepancies between the two most used techniques (liver to muscle ratio or calculation of the decay rate of the T2 * signal). Since the initial publications at 1.5 Tesla, new technical innovations have emerged which can allow better quantification. Recently, the investigators have applied these innovations to Rennes and have validated (SURFER study) the possibility of making a quantification of iron and fat on two 3 Tesla devices with good results in a single apnea acquisition. But it is not uncommon to have, in a structure, different magnetic field devices, and it is important to ensure that the results are transposable. It is also crucial for multicentre or cohort studies to ensure consistency. It is therefore proposed to compare the results of two examinations at 1.5 and 3 Tesla obtained on the same day on a series of 80 patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Related to MRI
Other criteria
Measurement of the fat and iron
Measurement of the fat and iron
Time frame: Day 1
Bland and Altman method comparing the quantification of iron and liver fat provided by the two MRI devices in the same patient using the MRQuantif software developed by the imaging department of the University Hospital of Rennes :
Time frame: Day 1
Concordance of the estimation of the quantification of the iron and the hepatic fat provided by our method and those of the constructors
Time frame: Day 1
Intraclass correlation coefficients (ICCs) and Bland & Altmann between two acquisitions
Time frame: Day 1
Intraclass correlation coefficients (ICCs) and Bland & Altmann between two readers/readings
Rennes University Hospital
Other
Acronym: HEMOCOMPARE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02520609
Digestive System Diseases, Fatty Liver
Bethesda, Maryland, United States
View Trial DetailsNCT05493761
Bone Diseases, Bone Diseases, Metabolic
Thessaloniki, Greece
View Trial DetailsNCT07724067
Digestive System Diseases, Fatty Liver
Bari, Italy
View Trial DetailsNCT04682600
Digestive System Diseases, Fatty Liver
Boston, Massachusetts, United States
View Trial Details